Skip to main contentSkip to main content
You have permission to edit this article.

Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes

  • 0
Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes

FRIDAY, May 20, 2022 (HealthDay News) -- Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.

The first-in-class medicine works by activating glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors and is administered by injection under the skin once a week. The dose is adjusted as tolerated to meet blood glucose goals.

Approval was based on data from five clinical trials in which three different doses of Mounjaro (5 mg, 10 mg, and 15 mg) were evaluated as standalone therapy or in addition to other diabetes medicines. Researchers found that the hemoglobin A1c (HbA1c) levels of patients randomly assigned to receive 15 mg of Mounjaro as a standalone therapy were reduced by 1.6 percent more than levels of patients randomly assigned to placebo, and when combined with a long-acting insulin, levels were reduced by 1.5 percent more than placebo. Compared with semaglutide, insulin degludec, and insulin glargine, HbA1c levels with 15 mg of Mounjaro were reduced by 0.5, 0.9, and 1.0 percent more with 15 mg Mounjaro, respectively.

The average weight loss with 15 mg of Mounjaro was 15 pounds more compared with placebo and 23 pounds more when both were used with insulin. Compared with semaglutide, insulin degludec, and insulin glargine, average weight loss with 15 mg of Mounjaro was 12, 29, and 27 pounds more, respectively.

Commonly reported side effects of Mounjaro include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain. The FDA notes that Mounjaro caused thyroid C-cell tumors in rats, but it is unknown whether it causes such tumors in humans. Mounjaro is contraindicated in individuals with a personal or family history of medullary thyroid cancer and in those with multiple endocrine neoplasia syndrome type 2.

Approval was granted to Eli Lilly and Co.

More Information


Originally published on, part of the TownNews Content Exchange.

Build your health & fitness knowledge

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Through routine testing, stigma decreases and early detection and treatment increases. Testing is easier, faster, and more widely available than ever before. In addition to testing, old and new methods of risk reduction, such as condoms and PrEP, continue to help us prevent the spread of HIV. 

The race to be Illinois’ next governor is also a battle among billionaires, including two whose names won’t appear on Tuesday's primary ballot. Republican candidates Darren Bailey and Richard Irvin each has a benefactor with a different vision for the party. Businessmen Ken Griffin and Richard Uihlein have combined to pour more than $60 million into the race. Griffin backs Irvin, a former prosecutor and first Black mayor of Chicago's largest suburb. Uihlein supports Bailey, a farmer and state lawmaker who fought pandemic measures such as mask mandates. Billionaire Democratic Gov. J.B. Pritzker and the Democratic Governors Association have spent millions trying to ensure Irvin isn’t the GOP nominee. Bailey is the opponent Pritzker would rather face in November.

Chinese leader Xi Jinping has said the conflict in Ukraine has “sounded an alarm for humanity," but proposed no solutions. China continues to assume a position of neutrality while backing its ally Russia by refusing to criticize its invasion of Ukraine or even to refer to it as an invasion in deference to Moscow, while also condemning U.S.-led sanctions against Russia. Xi was speaking at the opening of a virtual business forum of the BRICS countries — Brazil, Russia, India, China, and South Africa. In other comments, Xi said imposing sanctions could act as a “boomerang” and a “double-edged sword,” and that the global community would suffer from “politicizing, mechanizing and weaponizing" global economic trends and financial flows.

Thousands of dogs are competing at the illustrious Westminster Kennel Club Dog Show. Judging toward the best in show prize began Monday. Some basics on the big show: It features more than 3,000 canines, as wee as Chihuahuas and as massive as mastiffs. The contestants represent 209 breeds and varieties. First, dogs go up against others of their breed. The winner from each breed moves on to a semifinal round, where they’re judged against others in their “group” – such as hounds, herding dogs or terriers. In the final round, the group winners compete for best in show, which will be awarded Wednesday night.

The Supreme Court has rejected Bayer’s appeal to shut down thousands of lawsuits claiming its Roundup weedkiller causes cancer. The justices on Tuesday left in place a $25 million judgment in favor of Edwin Hardeman, who says he developed cancer from using Roundup for decades to treat poison oak, overgrowth and weeds on his San Francisco Bay Area property. Hardeman’s lawsuit had served as a test case for thousands of similar lawsuits. The high court’s action comes amid a series of court fights over Roundup that have pointed in different directions. Bayer argued federal regulators have repeatedly determined its products are safe. The German pharmaceutical company inherited Roundup when it acquired Monsanto in 2018.

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection. Saturday's announcement comes just days before regulators debate whether to offer Americans updated booster shots this fall. The current COVID-19 vaccines still offer strong protection against hospitalization and death. But protection against infection has dropped markedly with the omicron variant, and now its even more transmissible relatives are spreading. Pfizer says either an omicron-targeted booster or a combination shot that mixes the original vaccine with omicron protection substantially increases protection. Rival Moderna hopes to offer a similar combination shot.

As the World Health Organization convenes its emergency committee to consider if the spiraling outbreak of monkeypox warrants being declared a global emergency, some experts say WHO’s decision to act only after the disease spilled into the West could entrench the inequities that arose between rich and poor countries during the coronavirus pandemic. Many scientists also doubt any declaration would help to curb the epidemic, since the developed countries recording the most recent cases are already moving to shut it down. Monkeypox has sickened people for decades in central and west Africa. To date, no deaths have been seen outside Africa. The WHO said Thursday it did not expect to announce any decisions by its emergency committee before Friday.

Get up-to-the-minute news sent straight to your device.



Breaking News

Breaking Sports News

News Alert